Marianna Adamo, Luca Branca, Elisa Pezzola, Francesco Saia, Thomas Pilgrim, Mohamed Abdel-Wahab, Philippe Garot, Caterina Gandolfo, Claudia Fiorina, Sofia Sammartino, Azeem Latib, Ignacio Amat Santos, Darren Mylotte, Federico De Marco, Ole De Backer, Luis Nombela Franco, Mariama Akodad, Flavio Luciano Ribichini, Francesco Bedogni, Giulia Laterra, Alessandro Mazzapicchi, Daijiro Tomii, Pietro Laforgia, Stefano Cannata, Andrea Scotti, Simone Fezzi, Enrico Criscione, Enrico Poletti, Mattia Mazzucca, Roberto Valvo, MattiaLunardi, Andrea Mainardi, Stefano Andreaggi, Angelo Quagliana, Nicholas Montarello, Breda Hennessey, Matias Mon-Noboa, David Meier, Carmelo Sgroi, Claudia Maria Reddavid, Orazio Strazzieri, Silvia Crescenzia Motta, Valentina Frittitta, Elena Dipietro, Alessandro Comis, Chiara Melfa, Mariachiara Calì, Holger Thiele, John G Webb, Lars Sondergaard, Corrado Tamburino, Marco Metra, Giuliano Costa, Marco Barbanti
Evidence regarding sex-related differences in response to transcatheter aortic valve implantation according to the valve type is lacking. This study sought to evaluate the impact of sex on the treatment effect of Evolut-PRO/PRO+ (PRO) or Sapien 3 Ultra (ULTRA) devices on clinical outcomes. Comparative Analysis of Evolut PRO vs Sapien 3 Ultra Valves for Transfemoral Transcatheter Aortic Valve Implantation (OPERA-TAVI) is a multicenter multinational registry including patients undergoing latest-iteration PRO or ULTRA implantation...
February 22, 2024: American Journal of Cardiology